Dr. Bradley Prestidge, MD, MS, serves as Regional Medical Director of Radiation Oncology for Bon Secours Medical Group in Norfolk, Va. During the American Brachytherapy Society 2018 Annual Meeting, Dr. Prestidge shared with us his opinion on brachytherapy’s top...
Between a radiation oncologist’s caseload, administrative responsibilities and personal life, keeping tabs on – or even conducting – new research is a difficult task. Capitalizing on the same value ASTRO provides for radiation oncologists to connect with...
Radiation oncologists representing the University of Maryland School of Medicine and the Prostate Cancer Foundation of Chicago recently reported, “LDR-BT, primarily as a boost in conjunction with ADT and EBRT, is not only feasible, but also highly effective in men...
Year over year fourth quarter revenues increased 17% Sixth Consecutive Quarter of Year-Over-Year Revenue Increases Full year revenues increased 24% RICHLAND, Wash., September 25, 2018 — IsoRay (NYSE AMERICAN: ISR), a medical technology company and innovator in...
Dr. John Sylvester is considered a pioneer in prostate cancer brachytherapy. He has performed over 6,000 prostate brachytherapy procedures to date. Dr. Sylvester is currently a Radiation Oncologist at 21st Century Oncology in Lakewood Ranch, Florida. Dr. Sylvester has...
The past 12 to 18 months have seen remarkable new scientific evidence come to light regarding the attributes and benefits of brachytherapy, including Cesium-131, for prostate cancer treatment. This newly disseminated scientific evidence shows men treated with...
Roughly the same number of American men will be diagnosed with prostate cancer (1 in 9) as women will be diagnosed with breast cancer (1 in 8) every year. However, for a variety of reasons, prostate cancer awareness does not employ the same level of awareness breast...
Dr. Brian J. Moran, Medical Director for the Chicago Prostate Cancer Center, stresses the importance of customizing each and every patient’s cancer treatment. “This disease is a spectrum disease,” says Moran. “It’s not one-size-fits-all so we have to identify where...
Dr. Brian J. Moran is the Medical Director for the Chicago Prostate Cancer Center. The Chicago Prostate Cancer Center is a specialty center that practices low-dose rate brachytherapy and has performed over 20,000 low-dose rate prostate implants since they were founded...
Prostate cancer is one of the deadliest and most common cancers among men today. A recent article written by Melissa Matthews published by Newsweek reveals that late detection plays a key role in why prostate cancer is so fatal. Matthews writes in the article:...
